ATE282409T1 - Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte - Google Patents

Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte

Info

Publication number
ATE282409T1
ATE282409T1 AT00922845T AT00922845T ATE282409T1 AT E282409 T1 ATE282409 T1 AT E282409T1 AT 00922845 T AT00922845 T AT 00922845T AT 00922845 T AT00922845 T AT 00922845T AT E282409 T1 ATE282409 T1 AT E282409T1
Authority
AT
Austria
Prior art keywords
glutathione
synergize
carnitine
absorption
effects
Prior art date
Application number
AT00922845T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE282409T1 publication Critical patent/ATE282409T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00922845T 1999-04-16 2000-04-07 Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte ATE282409T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000230A IT1306130B1 (it) 1999-04-16 1999-04-16 Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
PCT/IT2000/000129 WO2000062773A1 (en) 1999-04-16 2000-04-07 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects

Publications (1)

Publication Number Publication Date
ATE282409T1 true ATE282409T1 (de) 2004-12-15

Family

ID=11406677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922845T ATE282409T1 (de) 1999-04-16 2000-04-07 Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte

Country Status (25)

Country Link
US (1) US6306392B1 (de)
EP (1) EP1087762B1 (de)
JP (1) JP2002542191A (de)
KR (1) KR20010071467A (de)
CN (1) CN1300214A (de)
AR (1) AR033325A1 (de)
AT (1) ATE282409T1 (de)
AU (1) AU774191B2 (de)
BR (1) BR0006045A (de)
CA (1) CA2334919C (de)
DE (1) DE60015893T2 (de)
EE (1) EE200000732A (de)
ES (1) ES2232443T3 (de)
HU (1) HU229272B1 (de)
IL (1) IL139851A0 (de)
IS (1) IS5740A (de)
IT (1) IT1306130B1 (de)
NO (1) NO20006285L (de)
NZ (1) NZ509276A (de)
PL (1) PL213130B1 (de)
PT (1) PT1087762E (de)
SK (1) SK18852000A3 (de)
TN (1) TNSN00077A1 (de)
TR (1) TR200003688T1 (de)
WO (1) WO2000062773A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306147B1 (it) * 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
KR100528720B1 (ko) * 2002-08-29 2005-11-15 주식회사 메디넥스 중금속 제거용 특수 영양식품
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
DK1817058T3 (en) * 2004-11-24 2015-12-07 Hills Pet Nutrition Inc COMPOSITION FOR USE FOR IMPROVING THE hepatic clearance xenobiotics WITH AN ANIMAL
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5295567B2 (ja) 2004-12-30 2013-09-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢期の動物の生活の質を高めるための方法
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
JP4831540B2 (ja) * 2005-08-26 2011-12-07 株式会社興人 経口催眠剤及び催眠性飲食物
JP2009107962A (ja) * 2007-10-29 2009-05-21 Asahi Breweries Ltd 酵母エキス含有組成物
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
CN103478718B (zh) * 2013-09-27 2015-10-28 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的功能食品及其制备方法
CN103535721B (zh) * 2013-09-27 2016-04-06 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的组合物及其制备方法和应用
CN103750344B (zh) * 2014-01-25 2015-11-04 北京凯因科技股份有限公司 一种酵母谷胱甘肽营养配制品
IL261670B (en) * 2018-09-06 2019-06-30 Tudu Holdings Ltd A preparation that includes magnesium and its uses
JP7478517B2 (ja) * 2019-04-24 2024-05-07 三菱商事ライフサイエンス株式会社 脂質活性代謝改善組成物
KR102559814B1 (ko) * 2021-05-14 2023-07-26 가톨릭대학교 산학협력단 글루타치온을 유효성분으로 포함하는 신장질환 치료용 약학적 조성물
KR102535328B1 (ko) * 2022-10-18 2023-05-26 주식회사 청안오가닉스 흑후추 추출물을 함유하여 글루타치온의 체내 흡수율을 높인 건강기능 식품용 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
HU229272B1 (en) 2013-10-28
JP2002542191A (ja) 2002-12-10
HUP0102501A2 (hu) 2001-11-28
DE60015893D1 (de) 2004-12-23
IL139851A0 (en) 2002-02-10
EE200000732A (et) 2002-06-17
NO20006285L (no) 2001-02-12
DE60015893T2 (de) 2005-12-01
KR20010071467A (ko) 2001-07-28
SK18852000A3 (sk) 2001-06-11
ITRM990230A1 (it) 2000-10-16
NZ509276A (en) 2002-09-27
EP1087762A1 (de) 2001-04-04
TNSN00077A1 (fr) 2002-05-30
IS5740A (is) 2000-11-28
NO20006285D0 (no) 2000-12-11
IT1306130B1 (it) 2001-05-30
EP1087762B1 (de) 2004-11-17
TR200003688T1 (tr) 2001-06-21
US6306392B1 (en) 2001-10-23
CA2334919C (en) 2009-02-24
AU774191B2 (en) 2004-06-17
PL344790A1 (en) 2001-11-19
HUP0102501A3 (en) 2002-12-28
AR033325A1 (es) 2003-12-17
CN1300214A (zh) 2001-06-20
PT1087762E (pt) 2005-03-31
BR0006045A (pt) 2001-03-13
ES2232443T3 (es) 2005-06-01
PL213130B1 (pl) 2013-01-31
AU4311700A (en) 2000-11-02
WO2000062773A1 (en) 2000-10-26
CA2334919A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
ATE282409T1 (de) Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte
DE69829863D1 (de) Siegelzusammentsetzung und diese enthaltende artikel
ID27862A (id) Metode-metode untuk pengontrolan bau badan sekitar pada tubuh yang menggunakan komposisi-komposisi yang terdiri dari senyawa non-komplek siklodekstrins dan pewangi
ID21236A (id) Penggunaan komposisi bioaktif yang dikapsulkan
ATE251130T1 (de) Neue 3-aryl-propionsäurederivate und analoge
DE60002696D1 (de) Redundanzbeseitigung in der persistenz von objektgraphen
DE69901396D1 (de) Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
ID25752A (id) Senyawa-senyawa piretroid dan komposisi untuk mengontrol hama yang mengandung senyawa-senyawa tersebut
DE69800469D1 (de) Pulverförmige ascorbinsaüre enthaltende kosmetische und/oder dermatologische zusammensetzung
DE69830919D1 (de) Verwendung von ascorbinsäure in dauerhaften haarverformungs- und haarfärbezusammensetzungen
NO20015849L (no) Blandinger inneholdende kreatin i suspensjon
ATE333264T1 (de) Wässrige kosmetische zusammensetzung mit verbesserter stabilität
DE69725894D1 (de) Transparente pulverbeschichtungszusammensetzung zum schutz von oberflächen
DE69814100D1 (de) Verschluss von absorbierenden artikeln
DE60042552D1 (de) Metabolische manipulation der produktion von aminosäuren
DE69903520D1 (de) Turbinenschaufelbefestigung mit kronen zur reduzierung von spannungen
DE60010747D1 (de) Neue trisubstituierte phenyl-derivate und analoga
DE60317639D1 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
NO20002797L (no) Flytende sammensetning inneholdende minoxidil
DE69825485D1 (de) Styrol-copolymer-zusammensetzungen mit vermindertem oberflächenglanz und diese enthaltende verbundwerkstoffe
DE69702905D1 (de) Polyaminosäure zur verbesserung der absorption eines insektizids
DK0949221T3 (da) Sammensætning, som er egnet som flydende gödning og som indeholder svovl i form af kaliumtetrathionat
DK0920329T3 (da) Stabilisering af interferoner i vandig opløsning med gummiarabicum
DE69815114D1 (de) Mepiquat pflanzenwachstumsregulatorzusammensetzung mit gesteigerter wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1087762

Country of ref document: EP